Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Artelo Biosciences, Inc. (ARTL) had Normalized Pre-Tax Income of $-2.96M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.96M |
|
-- |
|
-- |
|
$2.69M |
|
$-2.69M |
|
$-0.27M |
|
$-2.96M |
|
|
Normalized Pre-Tax Income |
$-2.96M |
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.69M |
|
$-2.60M |
|
0.74M |
|
0.74M |
|
$-4.00 |
|
$-4.00 |
|
| Balance Sheet Financials | |
$10.42M |
|
-- |
|
$2.10M |
|
$12.52M |
|
$5.83M |
|
-- |
|
$0.02M |
|
$5.85M |
|
$6.67M |
|
$4.63M |
|
$6.67M |
|
0.88M |
|
| Cash Flow Statement Financials | |
$-1.19M |
|
-- |
|
$10.86M |
|
$0.60M |
|
$10.27M |
|
$9.67M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.79 |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-44.33% |
|
-63.85% |
|
-23.63% |
|
-44.33% |
|
$7.62 |
|
$-1.61 |
|
$-1.61 |
|